The funds will go towards scaling C2N Diagnostics’ laboratory services and advancing the company’s range of diagnostic tests.

C2N Diagnostics, LLC, a specialty diagnostics company, has received a $10 million investment from Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment ...

Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...

The proof-of-concept showed, according to the corporations, how well artificial intelligence may raise network performance ...

According to a lawsuit, a former senior engineer alleged that he was wrongfully dismissed after reporting racial ...

St. Louis-based C2N said it will use the funds to scale its clinical laboratory services and Alzheimer's testing capabilities.

C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today ...

Late last year, Samsung paired with Nvidia to carry out interoperability tests at Samsung Research's lab. The tests used ...

Samsung Electronics has announced that the company is working with Nvidia to advance AI-RAN technologies. This endeavor aims ...

Samsung showcased significant progress in technology and ecosystem development of AI-RAN, unlocking the full potential of software-based networks with ...